专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080176891A1 NOVEL COMPOUNDS 审中-公开
标题翻译：新型化合物
公开(公告)号：US20080176891A1
公开(公告)日：2008-07-24
申请号：US11858144
申请日：2007-09-20
申请人： Paul Bamborough , Michael David Barker , Sebastien Andre Campos , Richard Peter Charles Cousins , Paul Faulder , Heather Hobbs , Duncan Stuart Holmes , Michael John Johnston , John Liddle , Jeremy John Payne , John Martin Pritchard , Caroline Whitworth
发明人： Paul Bamborough , Michael David Barker , Sebastien Andre Campos , Richard Peter Charles Cousins , Paul Faulder , Heather Hobbs , Duncan Stuart Holmes , Michael John Johnston , John Liddle , Jeremy John Payne , John Martin Pritchard , Caroline Whitworth
IPC分类号： A61K31/437 , C07D221/04 , A61P29/00 , A61P19/02 , A61P11/06
CPC分类号： C07D471/04
摘要： The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I): and salts thereof.The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.
摘要翻译：本发明涉及某些新化合物。具体地，本发明涉及根据式（I）的化合物及其盐。本发明的化合物是激酶活性的抑制剂，特别是IKK2活性。

2. 发明授权

US07084148B2 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors 失效
标题翻译：取代的嘧啶作为选择性环氧合酶-2抑制剂
公开(公告)号：US07084148B2
公开(公告)日：2006-08-01
申请号：US10362745
申请日：2001-08-31
申请人： Malcolm Clive Carter , Alan Naylor , Martin Pass , Jeremy John Payne , Neil Anthony Pegg
发明人： Malcolm Clive Carter , Alan Naylor , Martin Pass , Jeremy John Payne , Neil Anthony Pegg
IPC分类号： C07D405/12 , A61K31/505
CPC分类号： C07D405/12
摘要： A compound of formula (I): and pharmaceutically acceptable derivatives thereof, wherein R1 is H or C1-6alkyl; R2 is wherein defines the point of attachment of the ring; and R3 is C1-6alkyl or NH2. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever, inflammation of a variety of conditions and diseases.
摘要翻译：式（I）化合物及其药学上可接受的衍生物，其中R 1是H或C 1-6烷基; R 2是其中限定环的连接点; R 3是C 1-6烷基或NH 2。式（I）化合物是COX-2的有效和选择性抑制剂，可用于治疗疼痛，发热，各种病症和疾病的炎症。

3. 发明申请

US20100267755A1 PYRIMIDINE DERIVATIVES 审中-公开
公开(公告)号：US20100267755A1
公开(公告)日：2010-10-21
申请号：US10477546
申请日：2002-05-23
申请人： Gianpaolo Bravi , Malcolm Clive Carter , Richard Howard Green , Jennifer Margaret Doughty , Charles David Hartley , Alan Naylor , Martin Pass , Jeremy John Payne , Neil Anthony Pegg
发明人： Gianpaolo Bravi , Malcolm Clive Carter , Richard Howard Green , Jennifer Margaret Doughty , Charles David Hartley , Alan Naylor , Martin Pass , Jeremy John Payne , Neil Anthony Pegg
IPC分类号： A61K31/505 , A61P29/00 , C07D239/42 , C07D403/12 , C07D405/12 , C07D409/12 , A61K31/506
CPC分类号： C07D239/42 , C07D401/12 , C07D405/12 , C07D409/12
摘要： The invention provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C1-2alkyl substituted by one to five fluorine atoms, C3-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl, C4-12bridged cycloalkyl, A(CR7R8)n and B(CR7R8)n; R3 is selected from the group consisting of C1-6alkyl, NH2 and R10CONH; R4 is C1-2alkyl substituted by one to five fluorine atoms; R5 is selected from the group consisting of H, C1-4alkyl, C1-2alkyl substituted with one to five fluorine atoms, halogen and C3-10cycloalkylC0-6alkyl, with the proviso that when R6 is H R5 is not H. R6 is selected from the group consisting of H, C1-4alkyl, C1-2alkyl substituted with one to five fluorine atoms, halogen, C1-4alkoxy, CN, NO2, C1-6alkylOCO, NH2CO, C1-6alkylNHCO, NH2, C1-6alkylNH, (C1-6alkyl)2N, (C1-6alkyl)2NCO, C1-6alkylCONH, NH2SO2, C1-6alkylNHSO2, (C1-6alkyl)2NSO2, C1-6alkylSO2NH, ArSO2NH, C1-6alkylSO2, ArSO2, C3-10cycloalkylC0-6alkyl, C3-6alkenyl and C3-6alkynyl, with the proviso that when R5 is H R6 is not H. R7 and R8 are independently selected from H or C1-6alkyl; A is an unsubstituted 5- or 6-membered heteroaryl or an unsubstituted 6-membered aryl, or a 5- or 6-membered heteroaryl or a 6-membered aryl substituted by one or more R9; R9 is selected from the group consisting of hydroxy, halogen, C1-6alkyl, C1-6alkyl substituted by one more fluorine atoms, C1-6alkoxy, C1-6alkoxy substituted by one or more F, NH2SO2 and C1-6alkylSO2; R10 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl; B is selected from the group consisting of defines the point of attachment of the ring; and n is 0 to 4. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever and inflammation of a variety of conditions and diseases.

4. 发明授权

US07498321B2 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents 失效
标题翻译： 17β-硫代硫酸钠17α-芳基羰氧基氧基雄甾烷衍生物作为抗炎剂
公开(公告)号：US07498321B2
公开(公告)日：2009-03-03
申请号：US10343842
申请日：2001-08-03
申请人： Keith Biggadike , Paul Jones , Jeremy John Payne
发明人： Keith Biggadike , Paul Jones , Jeremy John Payne
IPC分类号： A61K31/58 , C07J3/00 , C07J17/00 , C07J33/00 , C07J43/00
CPC分类号： C07J31/006
摘要： There are provided according to the invention compounds of formula (I) wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents —C(═O)-aryl or —C(═O)-heteroaryl; R3 represents hydrogen, methyl (which may be in either the α or β configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and——represents a single or a double bond; and salts and solvates thereof. There are also provided processes for preparing compounds of formula (I) and use of the compounds in therapy especially in the treatment of inflammatory and allergic conditions.
摘要翻译：根据本发明提供式（I）化合物，其中R 1表示C 1-6烷基或C 1-6卤代烷基; R 2表示-C（ - ） - 芳基或-C（-O） - 杂芳基; R3表示氢，甲基（其可以是α或β构型）或亚甲基; R4和R5相同或不同，各自表示氢或卤素; 和 - 表示单键或双键; 及其盐和溶剂合物。还提供了制备式（I）化合物的方法和该化合物在治疗中的用途，特别是用于治疗炎性和过敏性疾病。

5. 发明授权

US07074802B2 Pyrimidine derivatives as selective inhibitors of cox-2 失效
标题翻译：嘧啶衍生物作为cox-2的选择性抑制剂
公开(公告)号：US07074802B2
公开(公告)日：2006-07-11
申请号：US10477819
申请日：2002-05-23
申请人： Jennifer Doughty, legal representative , Charles David Hartley , Alan Naylor , Jeremy John Payne , Neil Anthony Pegg
发明人： Richard Howard Doughty, deceased
IPC分类号： C07D239/42 , A61K31/505
CPC分类号： C07D239/42
摘要： The invention thus provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl and C4-12bridged cycloalkyl; R3 is selected from the group consisting of C1-6alkyl, NH2 and R5CONH; R4 is selected from the group consisting of CH2F, CHF2, CF3CH2, CF3CHF and CF3CF2; and R5 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.
摘要翻译：因此，本发明提供式（I）化合物及其药学上可接受的盐，其中：R 1和R 2独立地选自H，C C 1-6烷基，C 2-6链烯基，C 3-6亚炔基，C 3-10环烷基C 0-6个烷基和C 4-12-12桥连环烷基; R 3选自C 1-6烷基，NH 2和R 5 CONH; R 4选自CH 2，CH 2，CH 3，CH 3，CH 3，CH 3， 2，CF 3 CHF和CF 3 3 CF 2; 和R 5选自H，C 1-6烷基，C 1-6烷氧基，C 1 C 1-6烷基，C 1-6烷基，苯基，HO 2 C 1-6烷基，C 1-6 C 1-6烷基，C 1-6烷基，C 1 -C 6烷基，C 1 -C 6烷基，C 1 -C 6烷基，烷基，C 1-6烷基，C 1-6烷基和C 1-6烷基CONHC 1-6烷基。式（I）化合物是COX-2的有效和选择性抑制剂，可用于治疗疼痛，发热，各种病症和疾病的炎症。

6. 发明授权

US07026327B2 Pyrimidine derivatives useful as selective COX-2 inhibitors 失效
公开(公告)号：US07026327B2
公开(公告)日：2006-04-11
申请号：US10477547
申请日：2002-05-23
申请人： Alan Naylor , Jeremy John Payne , Neil Anthony Pegg
发明人： Alan Naylor , Jeremy John Payne , Neil Anthony Pegg
IPC分类号： C07D239/34 , C07D401/12 , A61K31/505
CPC分类号： C07D239/34 , A61K31/505 , C07D401/12
摘要： The invention provides the compounds of formula (I) in which: R1 is selected from the group consisting of H, C1-6alkyl, C1-2alkyl substituted by one to five fluorine atoms, C3-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl, C4-12bridged cycloalkyl, A(CR4R5)n and B(CR4R5)n; R2 is C1-2alkyl substituted by one to five fluorine atoms; R3 is selected from the group consisting of C1-6alkyl, NH2 and R7CONH; R4 and R5 are independently selected from H or C1-6alkyl; A is an unsubstituted 5- or 6-membered heteroaryl or an unsubstituted 6-membered aryl, or a 5- or 6-membered heteroaryl or a 6-membered aryl substituted by one or more R6; R6 is selected from the group consisting of halogen, C1-6alkyl, C1-6alkyl substituted by one more fluorine atoms, C1-6alkoxy, C1-6alkoxy substituted by one or more F, NH2SO2 and C1-6alkylSO2; B is selected from the group consisting of where defines the point of attachment of the ring; R7 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl; and n is 0 to 4. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever and inflammation of variety of conditions and diseases.

7. 发明授权

US06780869B1 Pyrimidine derivatives 失效
标题翻译：嘧啶衍生物
公开(公告)号：US06780869B1
公开(公告)日：2004-08-24
申请号：US10130516
申请日：2002-05-16
申请人： Richard Howard Green , Charles David Hartley , Alan Naylor , Jeremy John Payne , Neil Anthony Pegg
发明人： Richard Howard Green , Charles David Hartley , Alan Naylor , Jeremy John Payne , Neil Anthony Pegg
IPC分类号： C07D23942
CPC分类号： C07D239/42
摘要： The invention provides the compounds of formula (I) and pharmaceutically acceptable derivatives thereof, in which: R1 and R2 are independently selected from H, C1-6 alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl or C4-12bridged cycloalkane; and R3 is C1-6alkyl or NH2. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever, inflammation and a variety of conditions and diseases.
摘要翻译：本发明提供式（I）化合物及其药学上可接受的衍生物，其中：R 1和R 2独立地选自H，C 1-6烷基，C 2-6烯基，C 3-6炔基，C 3-10环烷基C 0 C6烷基或C4-12桥连环烷烃; 和R 3是C 1-6烷基或NH 2。式（I）的化合物是COX-2的有效和选择性抑制剂，并且可用于治疗疼痛，发烧，炎症和多种病症和疾病。

8. 发明授权

US06537983B1 Anti-inflammatory androstane derivatives 有权
标题翻译：抗炎雄甾烷衍生物
公开(公告)号：US06537983B1
公开(公告)日：2003-03-25
申请号：US10066961
申请日：2002-02-04
申请人： Keith Biggadike , Paul Spencer Jones , Jeremy John Payne
发明人： Keith Biggadike , Paul Spencer Jones , Jeremy John Payne
IPC分类号： A61K3158
CPC分类号： A61K9/0075 , A61K9/008 , A61K31/18 , A61K31/573 , A61K31/58 , A61K45/06 , C07J17/00 , C07J31/00 , C07J33/002 , C07J43/003 , A61K2300/00
摘要： According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents —C(═O)-aryl or —C(═O)-heteroaryl; R3 represents hydrogen, methyl (which may be in either the &agr; or &bgr; configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and {overscore (-----)} represents a single or a double bond; and salts and solvates thereof together with a long-acting &bgr;2-adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of inflammatory disorders of the respiratory tract over a period of 24 hours or more.
摘要翻译：根据本发明的一个方面，提供了一种用于通过吸入给药的药物制剂，其包含式（I）化合物，其中R 1表示C 1-6烷基或C 1-6卤代烷基; R 2表示-C（= O） - 芳基或 -C（= O） - 杂芳基; R 3表示氢，甲基（其可以是α或β构型）或亚甲基; R 4和R 5相同或不同，各自表示氢或卤素; 和（过量的（-----表示单键或双键;以及其与长效β2-肾上腺素受体激动剂的盐和溶剂合物），该制剂在治疗呼吸道炎症性疾病中具有治疗上有用的作用 24小时以上。

9. 发明申请

US20100035917A1 PYRROLO[2,3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS 1KK2 INHIBITORS 审中-公开
标题翻译：作为1KK2抑制剂的吡咯并[2,3-B]吡啶-4-基 - 苯甲酰胺化合物
公开(公告)号：US20100035917A1
公开(公告)日：2010-02-11
申请号：US12442012
申请日：2007-09-20
申请人： Paul Bamborough , Michael David Barker , Sebastien Andre Campos , Richard Peter Charles Cousins , Paul Faulder , Heather Hobbs , Duncan Stuart Holmes , Michael John Johnston , John Liddle , Jeremy John Payne , John Martin Pritchard , Caroline Whitworth
发明人： Paul Bamborough , Michael David Barker , Sebastien Andre Campos , Richard Peter Charles Cousins , Paul Faulder , Heather Hobbs , Duncan Stuart Holmes , Michael John Johnston , John Liddle , Jeremy John Payne , John Martin Pritchard , Caroline Whitworth
IPC分类号： A61K31/437 , C07D471/04
CPC分类号： C07D471/04
摘要： The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to Formula (1) and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular 1KK2 activity.
摘要翻译：本发明涉及某些新化合物。具体地，本发明涉及根据式（1）的化合物及其盐。本发明的化合物是激酶活性的抑制剂，特别是1KK2的活性。

10. 发明申请

US20080317833A1 Novel Anti-Inflammatory Androstane Derivatives 审中-公开
标题翻译：新型抗炎安慰剂衍生物
公开(公告)号：US20080317833A1
公开(公告)日：2008-12-25
申请号：US12199991
申请日：2008-08-28
申请人： Keith Biggadike , Paul Jones , Jeremy John Payne
发明人： Keith Biggadike , Paul Jones , Jeremy John Payne
IPC分类号： A61K31/56 , A61K9/70 , A61K9/127 , A61K9/12 , A61K9/14 , A61K9/20
CPC分类号： C07J31/006
摘要： There are provided according to the invention pharmaceutical compositions comprising a compound of formula (I) wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents —C(═O)-aryl or —C(═O)-heteroaryl, wherein said heteroaryl is a 5 member heterocyclic aromatic ring containing 1-3 hetero atoms selected from N and S, or a 5 member heterocyclic aromatic ring containing 2-3 hetero atoms selected from N, O and S, or a 6 member heterocyclic aromatic ring containing 1-3 hetero atoms selected from N, O and S; R3 represents hydrogen, methyl (which may be in either the α or β configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and represents a single or a double bond; or a physiologically acceptably salt or solvate thereof; and another therapeutically active agent; in admixture with one or more physiologically acceptable diluents or carriers.
摘要翻译：根据本发明提供药物组合物，其包含式（I）化合物，其中R 1表示C 1-6烷基或C 1-6卤代烷基; R 2表示-C（-O） - 芳基或-C（-O） - 杂芳基，其中所述杂芳基是含有1-3个选自N和S的杂原子的5元杂环芳族环或含有 2-3个选自N，O和S的杂原子，或含有1-3个选自N，O和S的杂原子的6元杂环芳环; R3表示氢，甲基（其可以是α或β构型）或亚甲基; R4和R5相同或不同，各自表示氢或卤素; ＆lt; img id =“CUSTOM-CHARACTER-00001”he =“3.13mm”wi =“11.60mm”file =“US20080317833A1-20081225-P00001.TIF”img-content =“character”img-format =“tif”/ >表示单键或双键; 或其生理上可接受的盐或溶剂合物; 和另一种治疗活性剂; 与一种或多种生理上可接受的稀释剂或载体混合。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式